Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26205
Title: | Driver monitoring systems (DMS): The future of impaired driving management? | Austin Authors: | Hayley, Amie C ;Shiferaw, Brook;Aitken, Blair;Vinckenbosch, Frederick;Brown, Timothy L;Downey, Luke A | Affiliation: | Human Factors, Seeing Machines, Fyshwick, Australian Capital Territory, Australia Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, Australia Institute for Breathing and Sleep Department of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands The National Advanced Driving Simulator, University of Iowa, Iowa City, Iowa |
Issue Date: | 8-Apr-2021 | Date: | 2021-04-08 | Publication information: | Traffic Injury Prevention 2021; 22(4): 313-317 | Abstract: | Driver monitoring systems (DMS) are the next generation of vehicle safety technology. Broadly, these refer to the embedded, aftermarket wearable or vehicle-mounted devices that collect observable information about the operator to make real-time assessment of their capacity to perform the driving task. Integrating biobehavioral monitoring (primarily ocular metrics) with driving performance assessments, these systems function to infer driver state in real time to identify operator conditions that negatively affect driving (such as fatigue, inattention, or distraction). We review available methods used to infer driver state, as referenced against accepted models for optimal performance. Modeling our observations on deviation from predetermined performance thresholds used to trigger graded safety alerts, we suggest that many psychoactive substances produce alterations to biobehavioral processes including attentional and motor control, which affect performance indices in a manner already arguably captured by these technologies. Using these existing frameworks, there is considerable potential to similarly catalogue the effect of many common intoxicants known to negatively affect driving ability. This will provide safety-relevant and practical biological models for the development of next-generation multimodal DMS that integrate ocular and physiological variables sensitive to the effects of common and emergent psychoactive substances. These devices have tangible potential application across all areas of transportation, including aviation, rail, and all commercial and private vehicle systems. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26205 | DOI: | 10.1080/15389588.2021.1899164 | ORCID: | 0000-0002-4470-4718 0000-0002-6721-9352 0000-0001-7607-7344 0000-0002-1767-7742 0000-0001-7530-9801 0000-0001-5670-3192 |
Journal: | Traffic Injury Prevention | PubMed URL: | 33829941 | Type: | Journal Article | Subjects: | Driver monitoring system (DMS) alcohol driving drug impairment psychoactive |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.